nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Air pollution and health
|
Wong, Gary W K |
|
2014 |
2 |
1 |
p. 8-9 2 p. |
artikel |
2 |
Ambitious plans to improve respiratory health in Uganda
|
Green, Andrew |
|
2014 |
2 |
1 |
p. 31-32 2 p. |
artikel |
3 |
Asthma heterogeneity and severity—why is comprehensive phenotyping important?
|
Moore, Wendy C |
|
2014 |
2 |
1 |
p. 10-11 2 p. |
artikel |
4 |
Bronchiectasis: the arrival of better evidence
|
Goyal, Vikas |
|
2014 |
2 |
1 |
p. 12-13 2 p. |
artikel |
5 |
Changing perceptions in pulmonary hypertension
|
Gerges, Christian |
|
2014 |
2 |
1 |
p. 21-23 3 p. |
artikel |
6 |
COPD drugs: the urgent need for innovation
|
Vestbo, Jørgen |
|
2014 |
2 |
1 |
p. 14-15 2 p. |
artikel |
7 |
Early diagnosis of IPF: time for a primary-care case-finding initiative?
|
Antoniou, Katerina M |
|
2014 |
2 |
1 |
p. e1- 1 p. |
artikel |
8 |
Early feeding during critical illness
|
Bear, Danielle E |
|
2014 |
2 |
1 |
p. 15-17 3 p. |
artikel |
9 |
E-cigarettes—too fast, too young?
|
The Lancet Respiratory Medicine, |
|
2014 |
2 |
1 |
p. 1- 1 p. |
artikel |
10 |
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial
|
Rabe, Klaus F |
|
2014 |
2 |
1 |
p. 44-53 10 p. |
artikel |
11 |
Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial
|
Watz, Henrik |
|
2014 |
2 |
1 |
p. 63-72 10 p. |
artikel |
12 |
Emerging respiratory viral infections: MERS-CoV and influenza
|
Al-Tawfiq, Jaffar A |
|
2014 |
2 |
1 |
p. 23-25 3 p. |
artikel |
13 |
Idiopathic pulmonary fibrosis: on the move
|
Bouros, Demosthenes |
|
2014 |
2 |
1 |
p. 17-19 3 p. |
artikel |
14 |
Montelukast for postinfectious cough in adults: a double-blind randomised placebo-controlled trial
|
Wang, Kay |
|
2014 |
2 |
1 |
p. 35-43 9 p. |
artikel |
15 |
Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis
|
López-Campos, Jose Luis |
|
2014 |
2 |
1 |
p. 54-62 9 p. |
artikel |
16 |
New cystic fibrosis genetic tests bring hope and dilemmas
|
Arnold, Carrie |
|
2014 |
2 |
1 |
p. 30- 1 p. |
artikel |
17 |
New treatments for COPD: many miles still to go
|
Calverley, Peter M A |
|
2014 |
2 |
1 |
p. 6-7 2 p. |
artikel |
18 |
Novel gene linked to severe childhood asthma
|
Tanday, Sanjay |
|
2014 |
2 |
1 |
p. 30- 1 p. |
artikel |
19 |
Patient, Doctor, Father, Son
|
Mastrianni, David M |
|
2014 |
2 |
1 |
p. 33-34 2 p. |
artikel |
20 |
Pharmacogenetics of COPD: a role for the β2-adrenergic receptor gene?
|
Jensen, Camilla Steen |
|
2014 |
2 |
1 |
p. 3-4 2 p. |
artikel |
21 |
Postinfectious cough and pertussis in primary care
|
Grant, Cameron C |
|
2014 |
2 |
1 |
p. 2-3 2 p. |
artikel |
22 |
Progress in research on screening and genetics in lung cancer
|
Hirsch, Fred R |
|
2014 |
2 |
1 |
p. 19-21 3 p. |
artikel |
23 |
Respiratory disease and fertility are linked—but why?
|
Furlow, Bryant |
|
2014 |
2 |
1 |
p. 28- 1 p. |
artikel |
24 |
Respiratory infections in patients with cystic fibrosis undergoing lung transplantation
|
Lobo, Leonard J |
|
2014 |
2 |
1 |
p. 73-82 10 p. |
artikel |
25 |
The dream of making new lungs comes closer to fulfilment
|
Maurice, John |
|
2014 |
2 |
1 |
p. 29- 1 p. |
artikel |
26 |
The rise and fall of COPD mortality
|
Ekström, Magnus P |
|
2014 |
2 |
1 |
p. 4-6 3 p. |
artikel |
27 |
Tuberculosis: progress and challenges in product development and delivery
|
Pai, Madhukar |
|
2014 |
2 |
1 |
p. 25-27 3 p. |
artikel |